CERVIX | CERVICAL SCREENING [ISSN 1804-087X]
česky | english | sitemap


PARTNERS AND EXPERT GUARANTEE
 
Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GRANT SUPPORT OF THE PROJECT
 
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
 
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
 
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
 
NCI Bethesda System
HPV College

 

News

Archive

Year: 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008


The Lancet Oncology: 2 large trials provide further evidence that 1 dose of HPV vaccine could prevent the majority of cervical cancers
9.6.2015 EurekAlert Press Release | More information...

A single dose of the bivalent human papillomavirus (HPV) vaccine (Cervarix®, GlaxoSmithKline group of companies) may offer a similar level of protection against HPV-16/18 infections, which cause about 70% of cervical cancers, as the current two- and three-dose schedules, according to new research combining data from two large phase 3 trials published in The Lancet Oncology.

Results of personalised invitations of Czech citizens to cancer screening programmes in 2014
16.4.2015 Czech Ministry of Health, Institute of Biostatistics and Analyses of Masaryk University | More information...

The project of personalised invitations of citizens to cancer screening programmes was launched in the Czech Republic in January 2014. Women are invited to participate in breast cancer screening and cervical cancer screening; men and women are invited to participate in colorectal cancer screening. The project aims to enhance the current cancer prevention programmes, and to increase their participation rates; therefore, personalised invitations are sent to citizens who do not participate in cancer screening programmes in the long term, and thus are at a higher risk of developing cancer.

Most types of cancer not due to “bad luck”, says IARC
13.1.2015 IARC Press Release | More information...

The International Agency for Research on Cancer (IARC), the World Health Organization’s specialised cancer agency, strongly disagrees with the conclusion of a scientific report on the causes of human cancer published in Science on 2 January 2015 by Dr Cristian Tomasetti and Dr Bert Vogelstein.


Back